Recombinant Human CEACAM-1/CD66a Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 2244-CM
Key Product Details
Product Specifications
Source
Gln35-Gly428, with a C-terminal 10-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for rhCEACAM-1 inhibition of anti-CD3 induced IL-2 production is 50.0-200 ng/mL.
Formulation, Preparation and Storage
2244-CM
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 100 μg/mL in sterile PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: CEACAM-1/CD66a
Carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM-1; also BGP) is a 160 kDa member of the CEACAM branch of the CEA gene family of the immunoglobulin superfamily (1 - 3). It is one of seven human CEACAM subfamily genes that are essentially divided equally between type I transmembrane proteins (CEACAM-1, 3 & 4) and GPI-linked molecules (CEACAM-5-8). There is no CEACAM-2 in human. The gene for human CEACAM-1 codes for a 526 amino acid (aa) type I transmembrane protein that contains a 34 aa signal sequence, a 394 aa extracellular domain (ECD), a 24 aa transmembrane segment, and a 74 aa cytoplasmic region (4, 5). The ECD contains one N-terminal V-type Ig-like domain, followed by three C2-type Ig-like domains. It shows considerable glycosylation, including high mannose residues and (sialyl) LewisX (1). The cytoplasmic region shows one ITIM motif and a calmodulin binding site (1 - 3). In addition to the full length form, ten alternate splice forms have been reported (1, 4, 6, 7, 8). There are three soluble and seven transmembrane isoforms, with variations occurring in both the ECD and cytoplasmic region. All ten alternate splice forms contain the V-type Ig-like domain (aa’s 35 - 142). The three soluble forms also contain the first two C2-type Ig-like domains (aa’s 145 - 317), with differences coming in the third C2-type Ig-like domain (6). The seven transmembrane isoforms are highly divergent. Five of the seven contain the V-type plus the first two C2-type domains and then diverge considerably both in the ECD and cytoplasmic region. The remaining two contain only the V-type Ig-like domain, the transmembrane region, and either a full-length or truncated cytoplasmic tail (1, 8). The actual functions of the isoforms are unclear.
Full-length mouse and rat CEACAM-1 are approximately 57% aa identical to human CEACAM-1; in the V-type Ig-like domain, they are 58% and 56% aa identical, respectively. The full-length molecule is found on neutrophils, bile duct epithelium, activated NK cells, colonic columnar epithelium and endothelium. It is known to act as an intercellular adhesion molecule, forming both homotypic, and heterotypic bonds with CEA and CEACAM-6/NCA (3, 9). On neutrophils, CEACAM-1 also binds to dendritic cell CD-SIGN via its LeX moiety, inducing dendritic cell maturation and a subsequent Th1-type response (10,11).
References
- Beauchemin, N. et al. (1999) Exp. Cell Res. 252:243.
- Thompson, J. et al. (1992) Genomics 12:761.
- Waggener, C. and S. Ergun (2000) Exp. Cell Res. 261:19.
- Barnett, T.R. et al. (1989) J. Cell Biol. 108:267.
- Hinoda, Y. et al. (1988) Proc. Natl. Acad. Sci. USA 85:6959.
- Kuroki, M. et al. (1991) Biochem. Biophys. Res. Commun. 176:578.
- Barnett, T.R. et al. (1993) Mol. Cell. Biol. 13:1273.
- Watt, S.M. et al. (1994) Blood 84:200.
- Oikawa, S. et al. (1992) Biochem. Biophys. Res. Commun. 186:881.
- Klaas, P.J.M. et al. (2005) FEBS Lett. 579:6159.
- Bogoevska, V. et al. (2005) Glycobiology 16:197.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional CEACAM-1/CD66a Products
Product Documents for Recombinant Human CEACAM-1/CD66a Protein, CF
Product Specific Notices for Recombinant Human CEACAM-1/CD66a Protein, CF
For research use only